RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)
01-04-2024
-31-03-2029
01-04-2024
-31-03-2029
01-01-2016
-30-06-2021
01-01-2024
-31-12-2027
01-06-2022
-31-05-2027